谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Interferon-γ ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial.

Ifedayo M Adetifa,Martin O C Ota,David J Jeffries,Moses D Lugos,Abdulrahman S Hammond,Nicholas J Battersby,Patrick K Owiafe,Simon D Donkor,Martin Antonio,Hannah B Ibanga,Roger H Brookes,Peter Aka,Robert Walton,Richard A Adegbola,Philip C Hill

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2013）

引用 48|浏览49
暂无评分
关键词
latent tuberculosis infection,isoniazid,IFN-gamma release assays,clinical trial,ELISPOT reversion
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要